Revolution Medicines: "Strong Buy" As Acquisition Prospects Continue To Circle — Positive
RVMD Seeking Alpha — January 09, 2026Revolution Medicines (RVMD) remains a "Strong Buy", driven by advanced RAS [ON] inhibitor programs and robust clinical progress, notably with Daraxonrasib. Company's phase 3 RASolute-302 trial in metastatic PDAC RAS-mutant patients is a major catalyst, with data expected in 2026 and significant expansion potential. Buyout interest from major pharma, including rumored $28–32B bids, underscores RVMD's strategic value and enhances upside optionality.
Gap Faces Pressure: Can Old Navy & Gap Brands Offset Athleta's Reset? — Negative
GAP Zacks Investment Research — January 09, 2026GAP faces Athleta's prolonged reset, but strong comps at Old Navy raise the question of whether portfolio strength can offset the drag.
Are EV Stocks Still Worth Buying Amid Waning Sales And No More Tax Credits? — Neutral
TSLA 24/7 Wall Street — January 09, 2026Electric vehicle stocks haven't fared well ever since the EV tax credit expired on September 30, 2025.
3 Stocks That Benefit if Companies Cut Costs in 2026 — Neutral
ADP BILL PAYC MarketBeat — January 09, 2026We are entering a new earnings season. Earnings reports are crucial to understanding a company's outlook for revenue and profit in the coming quarters, especially as headwinds still exist in many sectors of the economy.
Securities Fraud Investigation Into Ardent Health, Inc. (ARDT) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz — Neutral
ARDT Business Wire — January 09, 2026LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 12, 2025, after market hours, Ardent released its third.
Joby to Benefit From Second Ohio Facility Acquisition: Here's How — Positive
JOBY Zacks Investment Research — January 09, 2026JOBY plans to double aircraft output by 2027 after buying a 700,000-square-foot Dayton facility, expanding Ohio operations and near-term capacity.
Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript — Neutral
JAZZ Seeking Alpha — January 09, 2026Jazz Pharmaceuticals plc (JAZZ) Discusses HERIZON-GEA-01 Phase III Trial Results for Zanidatamab in HER2+ GEA Transcript
CNBC's Julia Boorstin reports on Meta's nuclear deals.
If there was an oil supply glut, prices would be collapsing: Carlyle's Currie — Neutral
BNO CG DBO GUSH IEO OIH OIL PXJ UCO USO XOP CNBC Television — January 09, 2026CNBC's "The Exchange" team discusses commodities, including gold and oil, as well as President Trump's meeting with oil companies about Venezuela with Jeffrey Currie of the Carlyle Group.
S&P 500 Holds Its Bullish Pattern as the Elliott Waves Forecast 7300+ — Positive
IVV SPLG SPXL SPY SSO UPRO VOO FXEmpire — January 09, 2026The Elliott wave indicates the index is in a 3rd wave, with an ideal target of approximately 7250, followed by a 4th-wave pullback to ~7100 and another 5th-wave rally to approximately 7345-7490.
Stellantis scraps US plug-in hybrid sales, citing weak demand — Negative
STLA Reuters — January 09, 2026Chrysler parent Stellantis said on Friday it will stop selling plug-in hybrid versions of the Jeep Wrangler and Grand Cherokee, and the Chrysler Pacifica minivan, in the United States as it navigates soft demand and shifts its North American electrification strategy.
Meta Signs Deals With 3 Nuclear Energy Companies to Power Data Centers — Positive
META OKLO VST PYMNTS — January 09, 2026Meta signed agreements with three nuclear energy companies to help power its artificial intelligence-focused data centers.
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLC — Neutral
AQST GlobeNewsWire — January 09, 2026ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST) complied with federal securities laws. On January 9, 2026, Aquestive disclosed that it received a notice from the FDA that it “had identified deficiencies in the New Drug Application (NDA) submitted by the Company for its product candidate, Anaphylm™ (epinephrine) Sublingual Film, for the treatment of severe allergic reactions, including anaphylaxis, that preclude discussion of labeling and post-marketing commitments for Anaphylm.” Following this news, the price of the Company's stock dropped.
Scorpio Tankers Inc. Kicks Off Capital Link's 2026 Virtual Company Presentation Series — Neutral
STNG GlobeNewsWire — January 09, 2026NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Capital Link is hosting a series of online Company Presentations, during which the Senior Management teams of leading publicly listed maritime companies will present their business development, strategy, growth prospects, and overall sector outlook. On Wednesday, January 14, 2026, at 10:00 AM ET, Scorpio Tankers Inc. (NYSE: STNG) will kick off Capital Link's 2026 Virtual Corporate Presentation Series, which will continue in the weeks that follow with presentations by senior management teams from additional leading publicly listed maritime companies.
Here's What President Trump Said About Intel's CEO That's Boosting the Stock Friday — Positive
INTC Investopedia — January 09, 2026Intel's stock hit its highest point in nearly two years Friday, thanks to a social media post.
KLAR INVESTOR DEADLINE: Klarna Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
KLAR Newsfile Corp — January 09, 2026San Diego, California--(Newsfile Corp. - January 9, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to Klarna's offering documents issued in connection with Klarna's September 10, 2025 initial public offering (the "IPO"), have until February 20, 2026 to seek appointment as lead plaintiff of the Klarna class action lawsuit. Captioned Nayak v.
iPhone 17 Demand Lifts AAPL Supercycle, AI & Innovation "Question Mark" — Positive
AAPL Schwab Network — January 09, 2026The holiday season added muscle to Apple's (AAPL) iPhone 17 sales. @LikeFolio's data shows strong demand in the tail-end of 2025, something Megan Brantley believes offers a good set-up for 2026.
Toll Brothers Announces the Release of New Ranch Home Designs at Aurora Ridge at Great Sky in Canton, Georgia — Neutral
TOL GlobeNewsWire — January 09, 2026CANTON, Ga., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the release of two new home designs at Aurora Ridge at Great Sky, a premier community by Toll Brothers in the scenic hills of Cherokee County, Georgia.
Deadline Soon: Stride, Inc. (LRN) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit — Neutral
LRN Business Wire — January 09, 2026LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming January 12, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON STRIDE, INC. (LRN), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD.
Olin Corporation remains a "Buy" as shares trade at a compressed ~9x mid-cycle earnings, despite recent operational setbacks. The Q4 EBITDA miss is primarily due to one-time maintenance overruns at Freeport; operations have since normalized, but capex may need to rise to sustainable levels. Demand headwinds persist, especially from weak Chinese and U.S. construction, with 2026 results expected to be flat or slightly lower versus 2025.